GENIDA

GenIDA – which stands for Genetically determined Intellectual Disabilities and Autisum Spectrum Disorders – collects health data and medical history on individuals diagnosed with a multitude of conditions. Dr. Koolen has worked closely with GenIDA to craft a series of questions to capture this data. The data is analyzed and helps us to better understand and characterize the syndrome.

About GenIDA

This research opportunity is open to ALL individuals diagnosed with Koolen-de Vries Syndrome. Parents and caregivers are encouraged to sign-up with GenIDA and enter medical information regarding their child’s health history. As of November 2018, over 200 families have signed up and started entering data. KdVS Foundation is excited to see the community getting involved. Sharing this data with GenIDA and Drs. Koolen and de Vries is a critical step in further characterizing and understanding Koolen-de Vries Syndrome. Please read the statement from Dr. Koolen below and then sign-up today! Already signed up for GenIDA? Don’t forget to:

  • Log-in and complete the questionnaire
  • Set yourself a reminder to update information.

Read more about GenIDA on their website. Follow GenIDA on Facebook for periodic updates.

View the GenIDA May 2022 Flyer

“We encourage parents to share clinical information on their child via GenIDA. GenIDA is a family-oriented international online clinical database that collects medically relevant information on individuals with a rare genetic condition. It is a robust system that allows us to perform extensive data analysis. By means of using the digital opportunities of today, a unique chance now comes up to collect a large number of international data on the KdVS. The information is entered and updated via the parents / families and is crucial for the delineation of the clinical spectrum of many rare and previously unrecognized medical conditions. In fact, the parents are the expert and have answers to many questions. It is up to researchers and clinicians to collect, to summarize, and to interpret the data. By doing so we can describe the full spectrum of clinical features including longitudinal data. This might provide tools for tailor-made clinical follow-up, management protocols and, where possible, appropriate therapy. We are confident that such collected data can produce extremely useful information. This important data can only be collected if you cooperate in providing this information. A huge advantage of this registry is the fact that questionnaires are available in different languages (e.g. Dutch, English, French, Portuguese), so the information can reach a broad audience internationally. The confidentiality of the provided data is guaranteed and for KdVS there has been so much information provided that useful information can be generated from the registry already. Please help us to collect and make record of the symptoms and course of KdVS by means of completing the registry. You can create your account at: https://genida.unistra.fr/. Thank you, Dr. David Koolen``